"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH": Comment from Hartmann et al
J Thromb Haemost
.
2022 Nov;20(11):2711-2712.
doi: 10.1111/jth.15861.
Authors
Jan Hartmann
1
,
Joao D Dias
1
,
Guadalupe Garcia-Tsao
2
3
,
Evan G Pivalizza
4
Affiliations
1
Department of Medical Affairs, Clinical Development and Medical Safety, Haemonetics Corporation, Boston, Massachusetts, USA.
2
Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA.
3
VA CT Healthcare System, West Haven, Connecticut, USA.
4
Department of Anesthesiology, UT Health McGovern Medical School, Houston, Texas, USA.
PMID:
36271460
DOI:
10.1111/jth.15861
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Coagulation*
Humans
Liver Cirrhosis / complications
Liver Cirrhosis / diagnosis
Liver Cirrhosis / therapy
Thrombocytopenia* / diagnosis
Thrombocytopenia* / therapy